Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results

Lung Cancer

Volumn 62, Issue 1, 2008, Pages 113-119

  Zhao, Zhi hong ^a   Wang, Sheng fa ^a   Yu, Liang ^a   Wang, Ju ^a   Chang, Hao ^a   Yan, Wei li ^a   Zhang, Jian ^a   Fu, Kai ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cell line; Lung cancer; Overexpression; p14ARF; Pokemon; Prognosis

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA; POKEMON PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; SURVIVAL RATE; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 52149103352     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.02.014     Document Type: Article

References (14)

1. Pessler F., Pendergrast P.S., and Hernandez N. Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol Cell Biol 17 (1997) 3786-3798
2. Davies J.M., Hawe N., Kabarowski J., Huang Q.H., Zhu J., Brand N.J., et al. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 18 (1999) 365-375
3. Kukita A., Kukita T., Ouchida M., Maeda H., Yatsuki H., and Kohashi O. Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesi. Blood 94 (1999) 1987-1997
4. Maeda T., Hobbs R.M., Merghoub T., Guernah I., Zelent A., Cordon-Cardo C., et al. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433 (2005) 278-285
5. Maeda T., Hobbs R.M., and Pandolfi P.P. The transcription factor Pokemon: a new key player in cancer pathogenesis. Cancer Res 65 (2005) 8575-8578
6. Nicholson S.A., Okby N.T., Khan M.A., Welsh J.A., Mcmenamin M.G., Travis W.D., et al. Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma. Cancer Res 61 (2001) 5636-5643
7. Eymin B., Gazerri S., Brambilla C., and Brambilla E. Mdm2 overexpression and p14(ARF) inactivation are two mutually exchusive events in primay human lung tumors. Oncogene 21 (2002) 2750-2761
8. 5, Cytosine-phospho -guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer. Clin Cancer Res 10 (2004) 4734-4741
9. Kim W.Y., and Sharpless N.E. The regulation of INK/ARF in cancer and aging. Cell 127 (2006) 265-275
10. Rovin R.A., and Winn R. Pokemon expression in malignant glioma: an application of bioinformatics methods. Neurosurg Focus 19 (2005) E8
11. Cui M., Xu H., and Yang Y. Expression and clinical significance of pokemon protein in breast cancer. J Clin Surg 15 (2007) 399-401
12. Ji Y., He X.S., Ma Y., Zhu X.F., Zhang R., and Ou Z.H. Expression of Pokemon in hepatocellular carcinoma tissue, adjacent and far tissue, hepatocirrhosis and normal liver tissue. Chin J Exp Surg 24 (2007) 187-189
13. Lu C.D., Altieri D.C., and Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58 (1998) 1808-1812
14. Apostolopoulou K., Pateras I.S., Evangelou K., Tsantoulis P.K., Liontos M., Kittas C., et al. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. J Pathol 213 (2007) 294-302